 Author information
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
2The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
3The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
4Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
5Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
6Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
7Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
8School of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Brazil, Ribeirao Preto, São Paulo, Brazil.
9The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
10Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
11Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
12service d'anatomopathologie, Hôpital de l'Enfant-Jésus du Centre hospitalier universitaire de Québec, Université Laval, Quebec City, QC, Canada.
13Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
14National Cancer Institute, Bethesda, MD, USA.
15Department of Cellular and Molecular Pathology, Leeds Teaching Hospital NHS Trust, St James's University Hospital, Leeds, UK.
16The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
17The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Cancer and Cell Biology Division, the Translational Genomics Research Institute, Phoenix, AZ, USA.
18The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Department of Biopharmaceutical Convergence, Department of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeong gi-do, South Korea.
19The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.
20University of Leeds, Leeds, UK.
21Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
22Department of Public Health Sciences, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
23Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
24University of Leeds, Leeds, UK.
25The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
26The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
27Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
28The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
29The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
30Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH, USA; Center for Biomedical Informatics and Information Technology & Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
31Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
32Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
33Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
34Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia.
35Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
36Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
37Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA.
38Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
39Department of Neurosurgery, School of Medicine and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
40Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
41Academic Department of Neurosurgery, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
42Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zürich, Switzerland.
43Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zürich, Switzerland.
44The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
45University of Leeds, Leeds, UK.
46Department of Public Health Sciences, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
47Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, MI, USA.
48Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA; Department of Neurology, Columbia University Medical Center, New York, NY, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
49The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Department of Neurosurgery, Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands. Electronic address: roel.verhaak@jax.org.
|